Stephen J.LurieMD, PhD, Senior EditorIndividualAuthorJody W.ZylkeMD, Contributing EditorIndividualAuthor
To the Editor: Drs Hellinger and Young1 summarize premium impact estimates developed by
Charles River Associates (CR) and by the CBO for federal antitrust exemption
legislation. The CR analysis put the impact in the range of 3.6% to 17.7%.
In contrast, CBO found only a 1.9% increase. Hellinger and Young indicate
that there has been no study of the benefits of the legislation. In fact,
we have developed empirical estimates of the costs and benefits of such legislation.2
Foreman S, Emmons D, Wozniak G. Economic Consequences of Collective Bargaining by Physicians. JAMA. 2001;286(15):1837-1839. doi:10.1001/jama.286.15.1833